CompletedNot Applicable

Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot Study

United Kingdom150 participantsStarted 2016-06

Plain-language summary

This is a pilot study taking place at University Hospitals of North Midlands NHS Trust. Patients referred for MRI for possible prostate cancer will be invited to take part in the study. Following consent, participants will have an additional MRI sequence performed during their routine MRI called Double Inversion Magnetic Resonance Imaging (DIR-MRI). Participants scan images and prostate biopsy histology report (if applicable) will be reviewed by the research team.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients referred for prostate MRI for possible prostate cancer * Safe to undergo an MRI scan * Able to give informed consent Exclusion Criteria: * MRI referrals where prostate cancer is not the question * Patients who are not safe to undergo an MRI scan * Patients who have undergone prostate biopsy in the previous 10 weeks * Patients unable to give informed consent

What they're measuring

Lesion to Normal tissue Ratio (LNR) recorded for DIR-MRI and DCE-MRI

Timeframe: 3 months

Trial details

NCT IDNCT02939456

SponsorUniversity Hospitals of North Midlands NHS Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-04-12

View on ClinicalTrials.gov More Cancer of the Prostate trials